NewCoxib 200 mg (Celecoxib)

Adult dose

The minimum recommended dose of this medicine should be adjusted according to the patient and may be taken with or without food. ○ Adults: 1. Osteoarthritis (degenerative arthritis): Take 200 mg of celecoxib once daily, or 100 mg twice daily in divided doses. 2. Rheumatoid arthritis: Take 100 mg or 200 mg of celecoxib per dose twice daily. 3. Ankylosing spondylitis (AS): Administer 200 mg of celecoxib once daily, or 100 mg twice daily in divided doses. If no effect is observed after 6 weeks, the dose may be increased to 400 mg daily. If no effect is observed after 6 weeks at 400 mg daily, other treatment options should be considered. 4. Acute pain and primary dysmenorrhea: The recommended initial dose is 400 mg of celecoxib; if needed, an additional 200 mg may be administered on the first day of treatment. Starting on the second day, the recommended dose as needed is 200 mg per dose twice daily. ○ Patients with hepatic impairment: For patients with moderate hepatic impairment (Child-Pugh Class II), the dose should be reduced to approximately 50% of the recommended daily dose.

This medication should be discussed with a doctor or pharmacist if taken by individuals who consume alcohol daily in excess, as it may increase the risk of gastrointestinal bleeding. This medication may increase the risk of cardiovascular issues such as heart attack or stroke; therefore, it should be used at the lowest effective dose for the shortest duration. Due to the potential for ulcers or bleeding in the stomach, if symptoms such as chest pain, dyspepsia, black stools, or vomiting blood occur during use, immediate medical attention is required. Individuals with allergies to this medication or severely impaired kidney or liver function, or those with active stomach ulcers or inflammatory bowel disease should not take it. Individuals with reduced liver or kidney function, a history of hypertension or heart failure, asthma patients, and the elderly should use this medication with more caution and undergo regular medical monitoring. This medication may interact with various drugs, so if you are taking other medications, you must inform your doctor or pharmacist. Women who are pregnant or may become pregnant, as well as nursing mothers, should not use this medication, and women planning to become pregnant should proceed with caution. If dizziness or drowsiness occurs during use, it is advisable to avoid driving or operating machinery. Long-term use requires routine blood tests and monitoring of liver and kidney function for abnormalities. This medication cannot be used as an alternative to aspirin for the prevention of cardiovascular disease, and concurrent use with aspirin may increase the risk of gastrointestinal issues. If allergic symptoms such as skin rash, itching, blisters, or fever occur after taking this medication, use should be discontinued, and medical advice should be sought immediately. This medication is not recommended for use in children and adolescents as safety and efficacy have not been established. In the case of an overdose, symptoms such as vomiting, drowsiness, and abdominal pain may occur, and appropriate treatment should be sought immediately.

Gastrointestinal bleeding, cardiovascular thromboembolic events, myocardial infarction, stroke, perforation of the upper and lower gastrointestinal tracts, ulcers, bleeding, bronchitis, sinusitis, upper respiratory tract infections, urinary tract infections, pharyngitis, rhinitis, anemia, thrombocytopenia, hypersensitivity, insomnia, anxiety, confusion, dizziness, muscle hypertonia, drowsiness, blurred vision, tinnitus, palpitations, congestive heart failure, arrhythmia, tachycardia, hypertension, flushing, cough, vomiting, abdominal pain, diarrhea, dyspepsia, bloating, gastric ulcer, dental diseases, duodenal ulcer, esophageal ulcer, intestinal perforation, pancreatitis, elevated liver enzymes, itching, rash, urticaria, petechiae, angioedema, alopecia, vesicular dermatitis, peripheral edema, facial edema, influenza-like illness, damage, dysgeusia, albuminuria, cystitis, hematuria, dysuria, polyuria, nephrolithiasis, incontinence, urinary tract infections, visual clouding, cataract, conjunctivitis, eye pain, glaucoma, retinal artery or vein occlusion, increased serum creatinine, elevated β2-microglobulin, increased NAG, positive urine hematuria, positive urine protein, renal dysfunction, acute renal failure, interstitial nephritis, elevated serum sodium, increased potassium levels, elevated BUN, increased CPK, diabetes mellitus, hypercholesterolemia, hyperglycemia, hypokalemia, hyperkalemia, increased NPN, increased creatinine, elevated alkaline phosphatase, weight gain, loss of appetite, increased LDH, hypoglycemia, hyponatremia, synovial bursa, arthralgia, arthritis, skeletal abnormalities, myalgia, cervical tension syndrome, synovitis, tendinitis, myositis, leg cramps, fractures, tendon rupture, pain in limbs, muscle stiffness, decreased hematocrit, increased hemoglobin, petechiae, nasal bleeding, thrombocytopathy, anemia, thrombocytopenia, agranulocytosis, aplastic anemia, pancytopenia, leukopenia, granulomatous inflammation, contact dermatitis, injection site reactions, skin nodules, chest pain, hallucinations, aseptic meningitis, cerebral hemorrhage, anaphylactoid reactions, pulmonary embolism, interstitial pneumonia, hepatitis, liver failure, fulminant hepatitis, liver necrosis, cholestasis, cholestatic hepatitis, jaundice, photosensitivity reactions, Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis, drug rash, acute generalized exanthematous pustulosis, exfoliative dermatitis, tubulointerstitial nephritis, nephrotic syndrome, minimal change disease, menstrual disorders, female infertility

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is safe to store at room temperature between 1 to 30 degrees Celsius.

Appearance

White oval film-coated tablets

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 100 tablets/bottle